Tamsulosin Hydrochloride Capsule
Product Images NDC 0115-8211

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 0115-8211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tamsulosin Hydrochloride Capsules 1)

Chemical structure diagram of the active ingredient Tamsulosin Hydrochloride, depicting its molecular composition including aromatic rings, functional groups, and hydrochloride component.*

FDA Label Image

Figure 1 (Tamsulosin Hydrochloride Capsules 2)

A pharmacokinetic concentration-time profile chart showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours) under fed and fasted conditions. The graph compares drug plasma levels with fed (solid line) versus fasted (dashed line) states, illustrating differences in absorption and concentration over a 36-hour period.*

FDA Label Image

Figure 2a (Tamsulosin Hydrochloride Capsules 3)

A line graph depicting mean change over treatment duration in weeks for Tamsulosin Hydrochloride at doses 0.4 mg and 0.8 mg compared to placebo. The graph shows decreasing mean values over time for treatment groups with placebo remaining higher. Symbols represent different treatment groups with sample sizes noted below x-axis time points.*

FDA Label Image

Figure 2b (Tamsulosin Hydrochloride Capsules 4)

A line graph showing mean change over duration of treatment in weeks for Tamsulosin Hydrochloride 0.4 mg and 0.8 mg capsules compared to placebo. The x-axis represents treatment duration (up to 13 weeks), and the y-axis shows mean change. Symbols distinguish treatment groups: circles for 0.8 mg, triangles for 0.4 mg, and squares for placebo.*

FDA Label Image

Figure 3a (Tamsulosin Hydrochloride Capsules 5)

A line graph showing mean change in a metric (mL/sec) over duration of treatment in weeks. The graph compares three groups: Treatment 0.8 mg, Treatment 0.4 mg, and Placebo, with mean change values plotted across multiple time points up to 13 weeks and LOCF (last observation carried forward).*

FDA Label Image

Figure 3b (Tamsulosin Hydrochloride Capsules 6)

A line graph displaying mean change in mL/sec over the duration of treatment in weeks for Tamsulosin Hydrochloride at 0.8 mg and 0.4 mg dosages, compared to placebo. The x-axis represents treatment duration up to 13 weeks, and the y-axis shows mean change values. Three distinct lines represent each treatment group.*

FDA Label Image

Label (Tamsulosin Hydrochloride Capsules 7)

Label for Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, oral capsule. The label indicates a package of 100 capsules distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes dosage information and storage instructions along with a barcode and product NDC 0115-8211-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.